Neurochemical Research

, Volume 36, Issue 11, pp 1978–1983 | Cite as

Effects of Taurine on Nitric Oxide and 3-Nitrotyrosine Levels in Spleen During Endotoxemia

  • Filiz Sezen Bircan
  • Barbaros Balabanli
  • Nurten Turkozkan
  • Gonca Ozan
Original Paper

Abstract

Taurine (2-aminoethanesulfonic acid) is a free sulfur-containing β-amino acid which has antioxidant, antiinflammatory and detoxificant properties. In the present study, the role of endotoxemia on peroxynitrite formation via 3-nitrotyrosine (3-NT) detection, and the possible antioxidant effect of taurine in lipopolysaccharide (LPS)-treated guinea pigs were aimed. 40 adult male guinea pigs were divided into four groups; control, endotoxemia, taurine and taurine+endotoxemia. Animals were administered taurine (300 mg/kg), LPS (4 mg/kg) or taurine plus LPS intraperitoneally. After 6 h of incubation, when highest blood levels of taurine and endotoxin were attained, the animals were sacrificed and spleen samples were collected. The amounts of 3-nitrotyrosine and taurine were measured by HPLC, and reactive nitrogen oxide species (NOx) which are stable end products of nitric oxide was measured spectrophotometrically in spleen tissues. LPS administration significantly decreased the concentration of taurine whilst increased levels of 3-NT and NOx compared with control group. It was determined that taurine treatment decreased the levels of 3-nitrotyrosine and NOx in taurine+endotoxemia group. The group in which taurine was administered alone, contradiction to well-known antioxidant effect, taurine caused elevated concentration of 3-NT and NOx. This data suggest that taurine protects spleen against oxidative damage in endotoxemic conditions. However, the effect of taurine is different when it is administered alone. In conclusion, taurine may act as an antioxidant during endotoxemia, and as a prooxidant in healthy subjects at this dose.

Keywords

3-Nitrotyrosine Endotoxin Peroxynitrite Spleen Taurine 

References

  1. 1.
    Bian K, Murad F (2001) Diversity of endotoxin-induced nitrotyrosine formation in macrophage-endothelium-rich organs. Free Radic Biol Med 31:421–429PubMedCrossRefGoogle Scholar
  2. 2.
    Lin NT, Yang FL, Lee RP, Peng TC, Chen HI (2006) Inducible nitric oxide synthase mediates cytokine release: the time course in conscious and septic rats. Life Sci 78:1038–1043PubMedCrossRefGoogle Scholar
  3. 3.
    Yilmaz G, Gursoy-Ozdemir Y, Dogan AI, Gurdal H, Gedikoglu G, Dalkara T, Guc MO (2001) Spleen damage in endotoxaemic mice: the involvement of nitric oxide. J Physiol Pharmacol 52:729–744PubMedGoogle Scholar
  4. 4.
    Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A, Okabe K (2001) Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104:1171–1175PubMedCrossRefGoogle Scholar
  5. 5.
    Liu S, Adcock IM, Old RW, Barnes PJ, Evans TW (1993) Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 196:1208–1213PubMedCrossRefGoogle Scholar
  6. 6.
    Duncan MW (2003) A review of approaches to the analysis of 3-nitrotyrosine. Amino Acids 25:351–361PubMedCrossRefGoogle Scholar
  7. 7.
    Guc MO (1999) Endotoxin-endothelium interactions in low-perfusion state research. J Physiol Pharmacol 50:541–550PubMedGoogle Scholar
  8. 8.
    van der Vliet A, Eiserich JP, Kaur H, Cross CE, Halliwell B (1996) Nitrotyrosine as biomarker for reactive nitrogen species. Methods Enzymol 269:175–184PubMedCrossRefGoogle Scholar
  9. 9.
    Parratt JR (1997) Nitric oxide: a key mediator in sepsis and endotoxaemia? J Physiol Pharmacol 48:493–506PubMedGoogle Scholar
  10. 10.
    Sakemi K, Ohno Y, Tsuda M (1998) Nitrite/nitrate levels in blood and principal organs in rats treated with lipopolysaccharide. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku 116:101–106PubMedGoogle Scholar
  11. 11.
    Hofmann AF, Small DM (1967) Detergent properties of bile salts: correlation with physiological function. Annu Rev Med 18:333–376PubMedCrossRefGoogle Scholar
  12. 12.
    Timbrell JA, Waterfield CJ (1996) Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro Adv Exp Med Biol 403:125–134Google Scholar
  13. 13.
    Wu C, Miyagawa C, Kennedy DO, Yano Y, Otoni S, Matsui-Yuasa I (1997) Involvement of polyamines in the protection of taurine against the cytotoxicity of hydrazine or carbon tetrachloride in isolated rat hepatocytes. Chem Biol Interact 103:213–224PubMedCrossRefGoogle Scholar
  14. 14.
    Thurston JH, Hauhart RE, Dirgo JA (1980) Taurine: a role in osmotic regulation of mammalian brain and possible clinical significance. Life Sci 26:1561–1568PubMedCrossRefGoogle Scholar
  15. 15.
    Schuller-Levis GB, Park E (2004) Taurine and its chloramine: modulators of immunity. Neurochem Res 29:117–126PubMedCrossRefGoogle Scholar
  16. 16.
    Pasantes-Morales H, Wright CE, Gaull GE (1985) Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage. Biochem Pharmacol 34:2205–2207PubMedCrossRefGoogle Scholar
  17. 17.
    Takahashi K, Harada H, Schaffer SW, Azuma J (1992) Effect of taurine on intracellular calcium dynamics of cultured myocardial cells during the calcium paradox. Adv Exp Med Biol 315:153–161PubMedCrossRefGoogle Scholar
  18. 18.
    Hayes KC, Stephan ZF, Sturman JA (1980) Growth depression in taurinedepleted infant monkeys. J Nutr 110:2058–2064PubMedGoogle Scholar
  19. 19.
    Kulakowski EC, Maturo J (1984) Hypoglycemic properties of taurine not mediated by enhanced insulin release. Biochem Pharmacol 33:2835–2838PubMedCrossRefGoogle Scholar
  20. 20.
    Silva LA, Silveira PC, Ronsani MM, Souza PS, Scheffer D, Vieira LC, Benetti M, De Souza CT, Pinho RA (2011) Taurine supplementation decreases oxidative stress in skeletal muscle after eccentric exercise. Cell Biochem Funct 29:43–49PubMedCrossRefGoogle Scholar
  21. 21.
    Mehta TR, Dawson R (2001) Taurine is a weak scavenger of peroxynitrite and does not attenuate sodium nitroprusside toxicity to cells in culture. Amino Acids 20:419–433PubMedCrossRefGoogle Scholar
  22. 22.
    Tappaz ML (2004) Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem Res 29:83–96PubMedCrossRefGoogle Scholar
  23. 23.
    Duffy AJ, Nolan B, Sheth K, Collette H, De M, Bankey PE (2000) Inhibition of alveolar neutrophil immigration in endotoxemia is macrophage inflammatory protein 2 independent. J Surg Res 90:51–57PubMedCrossRefGoogle Scholar
  24. 24.
    Egan BM, Abdih H, Kelly CJ, Condron C, Bouchier-Hayes DJ (2001) Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep. Eur J Surg 167:575–580PubMedCrossRefGoogle Scholar
  25. 25.
    Kamisaki Y, Wada K, Nakamoto K, Kishimoto Y, Kitano M, Itoh T (1996) Sensitive determination of nitrotyrosine in humans by high-performance liquid chromatography. J Chromatogr B Biomed Appl 685:343–347PubMedCrossRefGoogle Scholar
  26. 26.
    Maruyama W, Hashizume Y, Matsubara K, Naoi M (1996) Identification of 3-nitro-l-tyrosine, a product of nitric oxide and superoxide, as an indicator of oxidative stress in the human brain. J Chromatogr B Biomed Appl 676:153–158PubMedCrossRefGoogle Scholar
  27. 27.
    Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analyses of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126:131–138PubMedCrossRefGoogle Scholar
  28. 28.
    McMahon GP, O’Kennedy R, Kelly MT (1996) High-performance liquid chromatographic determination of taurine in human plasma using pre-column extraction and derivatization. J Pharm Biomed Anal 14:1287–1294PubMedCrossRefGoogle Scholar
  29. 29.
    Nusetti S, Obregon F, Lima L (2006) Neuritic outgrowth from goldfish retinal explants, interaction of taurine and zinc. Adv Exp Med Biol 583:435–440PubMedCrossRefGoogle Scholar
  30. 30.
    Romanovsky AA, Petersen SR (2003) The spleen: another mystery about its function. Am J Physiol Regul Integr Comp Physiol 284:1378–1379Google Scholar
  31. 31.
    Molina PE, Qian L, Schuhlein D, Naukam R, Wang H, Tracey KJ, Abumrad NN (1998) CNI-1493 attenuates hemodynamic and pro-inflammatory responses to lps. Shock 10:329–334PubMedCrossRefGoogle Scholar
  32. 32.
    Kan W, Zhao KS, Jiang Y, Yan W, Huang Q, Wang J, Qin Q, Huang X, Wang S (2004) Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression. Shock 21:281–287PubMedCrossRefGoogle Scholar
  33. 33.
    Sanikidze TV, Tkhilava NG, Papava MB, Datunashvili IV, Gongadze MT, Gamrekelashvili DD, Bakhutashvili VI (2006) Role of free nitrogen and oxygen radicals in the pathogenesis of lipopolysaccharide-induced endotoxemia. Bull Exp Biol Med 142:211–215CrossRefGoogle Scholar
  34. 34.
    Erdem A, Sevgili AM, Akbiyik F, Atilla P, Cakar N, Balkanci ZD, Iskit AB, Guc MO (2008) The effect of taurine on mesenteric blood flow and organ injury in sepsis. Amino Acids 35:403–410PubMedCrossRefGoogle Scholar
  35. 35.
    Erdamar H, Turkozkan N, Balabanli B, Ozan G, Bircan FS (2007) The relationship between taurine and 3-nitrotyrosine level of hepatocytes in experimental endotoxemia. Neurochem Res 32:1965–1968PubMedCrossRefGoogle Scholar
  36. 36.
    Marcinkiewicz J, Grabowska A, Bereta J, Bryniarski K, Nowak B (1998) Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 40:27–38PubMedCrossRefGoogle Scholar
  37. 37.
    Nagl M, Hess MW, Pfaller K, Hengster P, Gottardi W (2000) Bactericidal activity of micromolar n-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob Agents Chemother 44:2507–2513PubMedCrossRefGoogle Scholar
  38. 38.
    Kim C, Chung JK, Jeong JM, Chang YS, Lee YJ, Kim YJ, Lee MC, Koh CS, Kim BK (1998) Uptake of taurine and taurine chloramine in murine macrophages and their distribution in mice with experimental inflammation. Adv Exp Med Biol 442:169–176PubMedGoogle Scholar
  39. 39.
    Marcinkiewicz J, Nowak B, Grabowska A, Bobek M, Petrovska L, Chain B (1999) Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology 98:371–378PubMedCrossRefGoogle Scholar
  40. 40.
    Park E, Quinn MR, Wright CE, Schuller-Levis G (1993) Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J. Leukoc Biol 54:119–124PubMedGoogle Scholar
  41. 41.
    Kim C, Park E, Quinn MR, Schuller-Levis G (1996) The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-α in the conditoned media is inhibited by taurine chloramine. Immunopharmacology 34:89–95PubMedCrossRefGoogle Scholar
  42. 42.
    Janssen HF, Lombardini JB, Lust RM (1983) Cardiac taurine levels during endotoxemia. Proc Soc Exp Biol Med 172:407–411PubMedGoogle Scholar
  43. 43.
    Engel JM, Muhling J, Weiss S, Karcher B, Lohr T, Menges T, Little S, Hempelmann G (2006) Relationship of taurine and other amino acids in plasma and in neutrophils of septic trauma patients. Amino Acids 30:87–94PubMedCrossRefGoogle Scholar
  44. 44.
    Chiarla C, Giovannini I, Siegel JH (2003) Co-variation of plasma sodium, taurine and other amino acid levels in critical illness. Amino Acids 24:89–93PubMedGoogle Scholar
  45. 45.
    Stapleton PP, Redmond HP, Bouchier-Hayes DJ (1997) Taurine and inflammation-A new approach to an old problem? J Leukoc Biol 61:231–232PubMedGoogle Scholar
  46. 46.
    Houdijk AP, Oostering SJ, Siroen MP, de Jong S, Richir M, Rijssenbeck AL, Teerlink T, van Leeuwen PA (2006) Hypertaurinemia in bile duct-ligated rats after surgery: the effect of gut endotoxin restriction on organ fluxes and oxidative status. JPEN J Parenter Enteral Nutr 30:186–193PubMedCrossRefGoogle Scholar
  47. 47.
    Parildar-Karpuzoglu H, Mehmetcik G, Ozdemirler-Erata G, Dogru-Abbasoglu S, Kocak-Toker N, Uysal M (2008) Effect of taurine treatment on pro-oxidantant/oxidant balance in livers and brains of old rats. Pharmacol Rep 60:673–678PubMedGoogle Scholar
  48. 48.
    Parildar H, Dogru-Abbasoglu S, Mehmetcik G, Ozdemirler G, Kocak-Toker N, Uysal M (2008) Lipid peroxidation potential and antioxidants in the heart tissue of β-alanine or taurine-treated old rats. J Nutr Sci Vitaminol 54:61–65PubMedCrossRefGoogle Scholar
  49. 49.
    Uchida S, Kwon HM, Yamauchi A, Preston AS, Marumo F, Handler JS (1992) Molecular cloning of the cDNA for an MDCK cell Na+ and Cl dependent taurine transporter that is regulated by hypetonicity. Proc Natl Acad Sci USA 89:8230–8234PubMedCrossRefGoogle Scholar
  50. 50.
    Jones DP, Miller LA, Chesney RW (1995) The relative roles of external taurine concentration and medium osmolality in the regulation of taurine transport in LLC-PKI and MDCK cells. Pediatr Res 37:227–232PubMedCrossRefGoogle Scholar
  51. 51.
    Bridges CC, Ola MS, Prasad PD (2001) Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells. Am J Physiol Cell Physiol 281:C1825–C1836PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Filiz Sezen Bircan
    • 1
  • Barbaros Balabanli
    • 1
  • Nurten Turkozkan
    • 2
  • Gonca Ozan
    • 3
  1. 1.Department of Biology, Faculty of ScienceGazi UniversityTeknikokullar, AnkaraTurkey
  2. 2.Department of Clinical Biochemistry, Faculty of MedicineGazi UniversityAnkaraTurkey
  3. 3.TubitakAnkaraTurkey

Personalised recommendations